Stay updated on Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial page.

Latest updates to the Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on the HIL-214 vaccine for gastroenteritis, which included detailed information about the study's design, participant criteria, and the impact of norovirus. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference32%
- Check39 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check83 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check97 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check104 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial page.